Advertisement

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R. Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L. Ebert, Pierre Fenaux, Richard A. Larson, Ross L. Levine, Francesco Lo-Coco, Tomoki Naoe, Dietger Niederwieser, Gert J. Ossenkoppele, Miguel Sanz, Jorge Sierra, Martin S. Tallman, Hwei-Fang Tien, Andrew H. Wei, Bob Löwenberg and Clara D. Bloomfield

Article Information

Citation 
vol. 129 no. 4 424-447
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted August 12, 2016
  • Accepted November 15, 2016
  • Published online January 26, 2017.

Article Versions


Contributors 
  • Hartmut Döhner, 1Department of Internal Medicine III, University of Ulm, Ulm, Germany;
  • Elihu Estey, 2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
  • David Grimwade, 3Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom;
  • Sergio Amadori, 4Department of Biomedicine and Prevention, Università di Roma “Tor Vergata,” Rome, Italy;
  • Frederick R. Appelbaum, 2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
  • Thomas Büchner, 5Department of Hematology/Oncology, University of Münster, Münster, Germany;
  • Hervé Dombret, 6Institut Universitaire d’Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France;
  • Benjamin L. Ebert, 7Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA;
  • Pierre Fenaux, 8Service d’Hématologie, Hôpital Saint-Louis, Paris, France;
  • Richard A. Larson, 9Department of Medicine, University of Chicago, Chicago, IL;
  • Ross L. Levine, 10Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
  • Francesco Lo-Coco, 4Department of Biomedicine and Prevention, Università di Roma “Tor Vergata,” Rome, Italy;
  • Tomoki Naoe, 11National Hospital Organization Nagoya Medical Center, Nagoya, Japan;
  • Dietger Niederwieser, 12Department of Hematology, Oncology and Hemostasis, University of Leipzig, Leipzig, Germany;
  • Gert J. Ossenkoppele, 13Department of Haematology, Vrije Universiteit University Medical Center, Amsterdam, The Netherlands;
  • Miguel Sanz, 14Department of Hematology, University Hospital La Fe, University of Valencia, Valencia, Spain;
  • Jorge Sierra, 15Hematology Department, Hospital de la Santa Creu i Sant Pau, Jose Carreras Leukemia Research Institute, Barcelona, Spain;
  • Martin S. Tallman, 10Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
  • Hwei-Fang Tien, 16Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;
  • Andrew H. Wei, 17Department of Clinical Hematology, The Alfred Hospital, Melbourne, Australia; 18Australian Centre for Blood Diseases, Monash University, Melbourne, Australia;
  • Bob Löwenberg, 19Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands; and
  • Clara D. Bloomfield, 20The Ohio State University Comprehensive Cancer Center, Columbus, OH

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output